Short Interest in cbdMD, Inc. (NYSEAMERICAN:YCBD) Expands By 446.5%

cbdMD, Inc. (NYSEAMERICAN:YCBD) saw a large growth in short interest in December. As of December 15th, there was short interest totaling 3,970,725 shares, a growth of 446.5% from the November 30th total of 726,585 shares. Based on an average daily trading volume, of 34,203,375 shares, the short-interest ratio is currently 0.1 days. Currently, 45.5% of the shares of the stock are short sold. Currently, 45.5% of the shares of the stock are short sold. Based on an average daily trading volume, of 34,203,375 shares, the short-interest ratio is currently 0.1 days.

cbdMD Trading Up 5.7%

cbdMD stock opened at $1.68 on Friday. The stock has a 50-day moving average price of $0.93 and a two-hundred day moving average price of $0.90. cbdMD has a 12 month low of $0.47 and a 12 month high of $6.54.

Insider Buying and Selling at cbdMD

In related news, major shareholder Clark R. Crosnoe sold 550,701 shares of the firm’s stock in a transaction dated Wednesday, December 17th. The stock was sold at an average price of $2.32, for a total value of $1,277,626.32. Following the sale, the insider directly owned 17,875 shares of the company’s stock, valued at $41,470. This trade represents a 96.86% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. 2.10% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On cbdMD

An institutional investor recently raised its position in cbdMD stock. Alesco Advisors LLC raised its position in cbdMD, Inc. (NYSEAMERICAN:YCBD) by 64.0% during the second quarter, according to its most recent filing with the SEC. The firm owned 68,513 shares of the company’s stock after purchasing an additional 26,748 shares during the period. Alesco Advisors LLC owned 0.77% of cbdMD worth $61,000 as of its most recent filing with the SEC. 7.18% of the stock is currently owned by hedge funds and other institutional investors.

cbdMD Company Profile

cbdMD, Inc (NYSEAMERICAN: YCBD) is a Charlotte, North Carolina–based producer and distributor of hemp-derived cannabidiol (CBD) products. Since its founding in 2018, the company has focused on developing a diverse portfolio of wellness offerings designed for human and pet use. Its product range includes tinctures, capsules, gummies, topicals, and pet-specific formulations, each developed to comply with U.S. Food and Drug Administration (FDA) guidelines for hemp-derived substances.

The company operates a vertically integrated business model, sourcing U.S.-grown hemp and overseeing manufacturing processes in cGMP-certified facilities.